SCHEMBL13439632

SCHEMBL13439632

O=C(N1Cc2ccc(CN3CCOCC3)cc2C1)C(F)(F)F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNJ1 P48048 1/20 0.48
NPC1 O15118 1/20 0.48
TP53 P04637 1/20 0.48
TSHR P16473 1/20 0.48
MAPK1 P28482 1/20 0.48
RAB9A P51151 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
NAMPT P43490 2/20 0.48
ROCK2 O75116 1/20 0.48
ABHD6 Q9BV23 4/20 0.47
HRH3 Q9Y5N1 2/20 0.46
ESR1 P03372 2/20 0.46
ESR2 Q92731 2/20 0.46
ABL1 P00519 1/20 0.46
KCNH2 Q12809 1/20 0.46
HPGD P15428 1/20 0.45
HIF1A Q16665 1/20 0.45
EPAS1 Q99814 1/20 0.45
MGLL Q99685 1/20 0.43
AOC3 Q16853 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14590634 0.83 HRH3 (0.52) NPC1TP53TSHRMAPK1RAB9A
SCHEMBL2333879 0.80 ESR1 (0.62) NAMPTROCK2ABHD6ESR1ESR2
SCHEMBL30368214 0.80 PIK3CA (0.49) NPC1TP53TSHRMAPK1RAB9A
SCHEMBL25669120 0.80 PIK3CA (0.49) NPC1TP53TSHRMAPK1RAB9A
SCHEMBL3060013 0.79 ESR1 (0.61) ABHD6HRH3ESR1ESR2HPGD
SCHEMBL25200985 0.78 ESR1 (0.51) ABHD6ESR1ESR2MGLLHSP90AA1
SCHEMBL13336895 0.78 MAPK1 (0.63) MAPK1SMN1; SMN2NAMPTABHD6HPGD
Trifluoroacetic Acid SCHEMBL383473 0.77 KCNJ1 (0.56) KCNJ1NPC1TP53TSHRMAPK1
SCHEMBL12853700 0.76 SMN1; SMN2 (0.57) NPC1TP53TSHRMAPK1RAB9A
SCHEMBL4713777 0.75 NAMPT (0.46) NPC1TP53TSHRMAPK1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9730912-B2 Pharmaceutical compounds ASTEX THERAPEUTICS LIMITED (GB) 2017-08-15 US disclosed
US-7700625-B2 Hydroxybenzamide derivatives and their use as inhibitors of Hsp90 ASTEX THERAPEUTICS LTD. (GB) 2010-04-20 US disclosed